Take a step forward in how you treat chronic diabetic nerve pain.
Spinal cord stimulation (SCS) for your patients with moderate to severe diabetic peripheral neuropathy (DPN) pain
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
For patients who experience chronic pain due to DPN and have not been satisfied by the levels of relief provided by oral pain medication, injections, or other treatments for pain, SCS can provide a new approach for patients looking for solutions.
SPINAL CORD STIMULATION
Spinal cord stimulation is a proven, non-opioid, FDA-approved way to manage chronic pain that may be caused by DPN. SCS works by disrupting the pain signals traveling between the spinal cord and the brain.
Stimulation is delivered via a Medtronic Intellis™ or Vanta™ neurostimulator, a device similar to a pacemaker, implanted under the skin.
more likely to
of patients experienced treatment success after receiving SCS therapy
Risks include infection, lead movement, pain at the implant site, and loss of therapy eﬀectiveness. Not everyone responds to SCS in the same way, and your patients’ experiences may vary. Risk of infection and severity of complications may be greater in diabetic patients.
Consider a preoperative risk assessment to determine if patients are healthy enough for surgery.
Monitor patients' glucose levels.
For a better understanding of risk and safety details associated with SCS therapy, and to get information about trials, procedures, benefits and features of Medtronic devices, download our brochures for referring physicians and implanters.
If you have additional questions about spinal cord stimulation, sign up to speak with a Medtronic representative.
Visit the, Medtronic SCS website for healthcare professionals to get more information.
Success rates in a population of patients treated with SCS in two studies and followed for five years.
Medtronic. Medtronic Pain Therapy Clinical Summary M221494A016 Rev B. United States; 2022.
de Vos CC, Meier K, Zaalberg PB, et al. Spinal cord stimulation in patients with painful diabetic neuropathy: A multicenter randomized clinical trial. Pain. 2014;155(11):2426–2431. doi:10.1016/j.pain.2014.08.031.
Slangen R, Schaper NC, Faber CG, et al. Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: A prospective two-center randomized controlled trial. Diabetes Care. 2014;37(11):3016–3024. doi:10.2337/dc14-0684.
van Beek M, Geurts JW, Slangen R, et al. Severity of neuropathy is associated with long-term spinal cord stimulation outcomes in painful diabetic peripheral neuropathy: Five-year follow-up of a prospective two-center clinical trial. Diabetes Care. 2018;41(1):32–38. doi:10.2337/dc17-0983.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.